Recognizing the value of scientific advances that are made outside of Novartis, we actively seek collaborators with the best technologies and early-stage compounds that complement our objectives. We have a culture designed to build fair, effective and mutually beneficial alliances.
The importance that we place on building winning collaborations is seen in the early and substantial involvement of our senior management. We devote the same level of commitment to licensed opportunities as to internally discovered product candidates. Our alliance and business development teams remain actively involved with each project throughout its duration to ensure effective communication and to foster an open, productive environment for collaboration.
Submit a proposal
We invite interested external parties to submit their project proposals (see below). In order for our internal review process to run as quickly and smoothly as possible, we encourage the inclusion of any non-confidential data describing the compound or technology in more detail. This will ensure a comprehensive and fair review by our internal experts.
For early discovery such as targets, software, assay tools, chemistry, biology, disease models, screening technology, imaging tools and pre-clinical (pre-Proof-of-concept) compounds, please submit a proposal.